Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Pamela DiPiro, M.D.

Concepts (192)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Referral and Consultation5202335280.960 Why?
Oncology Service, Hospital22017570.710 Why?
Carcinoma, Lobular220204840.620 Why?
Abdominal Neoplasms120192910.590 Why?
Physician Assistants120181930.540 Why?
Breast Neoplasms182023208170.540 Why?
Mammography12201824770.520 Why?
Radiology4202320990.450 Why?
Neoplasms, Second Primary2201910610.450 Why?
Fibrocystic Breast Disease520001020.440 Why?
Tomography, X-Ray Computed132023201230.430 Why?
Biopsy, Needle8200016400.380 Why?
Academic Medical Centers5202327590.370 Why?
Lymphoma, Large B-Cell, Diffuse2201713780.330 Why?
Breast8200019690.320 Why?
Cancer Care Facilities220184020.310 Why?
Inflammatory Breast Neoplasms220201430.300 Why?
Radiology Information Systems320215230.300 Why?
Lymphoma, T-Cell120092990.290 Why?
Medical Oncology1201822650.280 Why?
Liver Neoplasms2202042520.280 Why?
Neoplasm Metastasis3201648410.260 Why?
Evidence-Based Medicine1201736110.260 Why?
Radiology Department, Hospital220194120.230 Why?
Ultrasonography, Mammary520182500.220 Why?
Magnetic Resonance Imaging72021354230.220 Why?
Genes, erbB-2220141620.210 Why?
Stereotaxic Techniques520005350.200 Why?
Carcinoma, Ductal, Breast5202011010.200 Why?
Fluorodeoxyglucose F182202020170.190 Why?
Forms and Records Control120201600.170 Why?
Incidental Findings220206890.160 Why?
Multiple Pulmonary Nodules120201530.160 Why?
Calcinosis5200014990.150 Why?
Calcium Phosphates120181710.150 Why?
Solitary Pulmonary Nodule120202650.150 Why?
Retrospective Studies182023774260.140 Why?
Surgical Instruments119993950.140 Why?
Workload120028500.140 Why?
Tumor Burden2201419140.140 Why?
Environment1200211240.140 Why?
Lung Neoplasms62020130960.140 Why?
Neoplasms52017216720.140 Why?
Quality Improvement3202037460.130 Why?
Immunoconjugates120239010.130 Why?
Foreign Bodies119993990.130 Why?
Seat Belts11995570.130 Why?
Humans5020237442200.130 Why?
Positron-Emission Tomography4201762740.120 Why?
Patient Care Planning120209210.120 Why?
Receptors, Progesterone2202010970.120 Why?
Neoplasm Recurrence, Local4201792300.120 Why?
Female3720233801970.110 Why?
Terminology as Topic1202015480.110 Why?
Receptor, erbB-23202324160.110 Why?
Clinical Protocols1201814620.110 Why?
Radiopharmaceuticals2202026620.100 Why?
Carcinoma, Intraductal, Noninfiltrating119999490.100 Why?
Receptors, Estrogen2202021860.100 Why?
Genes, BRCA1120147810.090 Why?
Interprofessional Relations1201710090.090 Why?
Mucous Membrane120136680.090 Why?
Quinazolines2201413560.090 Why?
Breast Diseases319984430.090 Why?
Immunoblastic Lymphadenopathy12009350.090 Why?
Prognosis42019290500.090 Why?
Pleural Neoplasms120146070.090 Why?
Accidents, Traffic119958190.080 Why?
Contrast Media3201853000.080 Why?
Survival Analysis22019102500.080 Why?
Pulmonary Embolism2201223750.080 Why?
Leukemia-Lymphoma, Adult T-Cell120091660.080 Why?
Middle Aged2520202133670.080 Why?
Neoplasm Staging72020110070.080 Why?
Aged2120201632530.080 Why?
Delivery of Health Care, Integrated120169410.080 Why?
Lymphoma, Large-Cell, Anaplastic120091690.080 Why?
Nose Neoplasms120092460.070 Why?
Follow-Up Studies62020390450.070 Why?
Cone-Beam Computed Tomography120104500.070 Why?
Decision Support Techniques1201719550.070 Why?
Patient-Centered Care1201714380.070 Why?
Hodgkin Disease1201414150.070 Why?
Central Nervous System Neoplasms120148950.070 Why?
Adult2120202140350.070 Why?
Melanoma2201454750.070 Why?
Molecular Targeted Therapy1201727270.060 Why?
Diabetes Mellitus, Type 11199933360.060 Why?
Uterine Cervical Neoplasms1201620190.060 Why?
Carcinoma, Non-Small-Cell Lung2201452210.060 Why?
Aged, 80 and over92019577680.060 Why?
Carcinoma in Situ220008050.060 Why?
Antineoplastic Combined Chemotherapy Protocols22014114930.050 Why?
Radiation Injuries1201011780.050 Why?
Boston3201993110.050 Why?
Mass Screening1201852520.050 Why?
Bone Neoplasms1201425250.050 Why?
Brachytherapy1201012460.050 Why?
Physicians1202045640.050 Why?
Iohexol220141960.050 Why?
Radiography2202370220.050 Why?
Brain Neoplasms1202388600.050 Why?
Diagnosis, Differential32020129610.050 Why?
Camptothecin120235760.040 Why?
Gastrointestinal Stromal Tumors120056430.040 Why?
Antineoplastic Agents32017136680.040 Why?
Medical Record Linkage120192840.040 Why?
Workflow120228470.040 Why?
Treatment Outcome72023631190.040 Why?
Radiographic Image Enhancement220148850.040 Why?
Negotiating120181330.040 Why?
Ultrasonography, Interventional2200214830.040 Why?
Carcinoma, Squamous Cell1201240330.040 Why?
Male1120173500270.040 Why?
Radiographic Magnification11996200.040 Why?
Axilla120185950.030 Why?
Fibroadenoma11996430.030 Why?
Fat Necrosis11995580.030 Why?
Comprehensive Health Care120161270.030 Why?
Adenocarcinoma1201263520.030 Why?
Contusions11995810.030 Why?
Piperazines1200524910.030 Why?
Risk2201896850.030 Why?
Radiography, Interventional2199910950.030 Why?
Evaluation Studies as Topic1199616760.030 Why?
Data Collection1200233400.030 Why?
Pyrimidines1200529400.030 Why?
Antibodies, Neoplasm120142860.030 Why?
Lymph Node Excision1201812560.030 Why?
Models, Organizational120165740.030 Why?
Cysts119976790.030 Why?
Vinblastine120134900.030 Why?
Kaplan-Meier Estimate2201265350.020 Why?
Markov Chains120149690.020 Why?
Maytansine12011800.020 Why?
Mastectomy, Segmental119969560.020 Why?
Radiotherapy, Adjuvant1199617700.020 Why?
Biopsy2199967570.020 Why?
Mastectomy1201817930.020 Why?
Chemotherapy, Adjuvant1201834740.020 Why?
Ultrasonography2200059820.020 Why?
Skin Neoplasms1200956700.020 Why?
Estrogen Replacement Therapy1199612030.020 Why?
Vacuum22000650.020 Why?
Lymphocytes, Tumor-Infiltrating1201410390.020 Why?
Neoadjuvant Therapy1201827260.020 Why?
Life Expectancy1201411840.020 Why?
Risk Factors12014722800.020 Why?
Prospective Studies22023532800.020 Why?
Angiogenesis Inhibitors1201720380.020 Why?
Statistics, Nonparametric1201228860.020 Why?
Drug Administration Schedule1201449290.020 Why?
Lymphatic Metastasis1201329140.020 Why?
Radiation Dosage1201419280.020 Why?
Massachusetts1201886630.020 Why?
Cohort Studies22023405590.020 Why?
Observer Variation1201025930.020 Why?
Decision Making1201838880.020 Why?
Survivors1201422910.010 Why?
Neovascularization, Pathologic1201426360.010 Why?
Time Factors21996400630.010 Why?
Outpatients1201114860.010 Why?
Lymph Nodes1199334690.010 Why?
Cross-Sectional Studies12002250430.010 Why?
Dose-Response Relationship, Drug12014109490.010 Why?
Cost-Benefit Analysis1201453960.010 Why?
Diagnostic Imaging1201635080.010 Why?
Recurrence1201283430.010 Why?
Sex Factors12014103960.010 Why?
Early Detection of Cancer1201430860.010 Why?
Biomedical Research1201633110.010 Why?
Venous Thromboembolism1201216700.010 Why?
Benzamides1200513780.010 Why?
Multivariate Analysis12012122440.010 Why?
Automation120005840.010 Why?
Protein Kinase Inhibitors1201455290.010 Why?
Smoking1201489860.010 Why?
Age Factors12014183670.010 Why?
Hyperplasia1200011840.010 Why?
Anticoagulants1201245990.010 Why?
Imaging, Three-Dimensional1201040440.010 Why?
Image Processing, Computer-Assisted1201489500.010 Why?
Antibodies, Monoclonal1201492750.010 Why?
Reproducibility of Results12014199070.010 Why?
Chi-Square Distribution1200035090.010 Why?
Incidence12011209450.010 Why?
Neoplasm Invasiveness1200036140.010 Why?
Equipment Design1200035820.010 Why?
Lung1201098520.010 Why?
Young Adult12011564360.000 Why?
Case-Control Studies11997217520.000 Why?
Adolescent12005857590.000 Why?
DiPiro's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (192)
Explore
_
Co-Authors (62)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.